Agents targeting this mechanism could be expected to have effects on both types of disease because multiple cell types including mast cells, basophils, type 2 T‐helper cells, invariant natural killer cells and natural killer cells are involved in both T2‐driven and non–T2‐driven asthma and express IL‐33R.8 The gene discussed is IL1RL1; the disease is asthma.